Ecofibre Ltd - Asset Resilience Ratio

Latest as of December 2024: 6.67%

Ecofibre Ltd (EOF) has an Asset Resilience Ratio of 6.67% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check EOF PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$3.87 Million
≈ $2.74 Million USD Cash + Short-term Investments

Total Assets

AU$58.04 Million
≈ $41.07 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Ecofibre Ltd's Asset Resilience Ratio has changed over time. See Ecofibre Ltd balance sheet quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Ecofibre Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Ecofibre Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$3.87 Million 6.67%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$3.87 Million 6.67%

Asset Resilience Insights

  • Limited Liquidity: Ecofibre Ltd maintains only 6.67% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Ecofibre Ltd Industry Peers by Asset Resilience Ratio

Compare Ecofibre Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 11.69%
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
Drug Manufacturers - Specialty & Generic 6.62%
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131
Drug Manufacturers - Specialty & Generic 1.37%
Bausch Health Companies Inc
TO:BHC
Drug Manufacturers - Specialty & Generic 4.97%
Dezhan HealthCare Co Ltd
SHE:000813
Drug Manufacturers - Specialty & Generic 0.15%
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
Drug Manufacturers - Specialty & Generic 0.01%
Hainan Haiyao Co Ltd
SHE:000566
Drug Manufacturers - Specialty & Generic 3.27%
Shanxi Zhendong Pharmaceutical
SHE:300158
Drug Manufacturers - Specialty & Generic 10.74%

Annual Asset Resilience Ratio for Ecofibre Ltd (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Ecofibre Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-06-30 0.28% AU$200.00K
≈ $141.51K
AU$71.25 Million
≈ $50.41 Million
-0.01pp
2023-06-30 0.29% AU$347.00K
≈ $245.52K
AU$118.73 Million
≈ $84.01 Million
-4.69pp
2022-06-30 4.99% AU$7.46 Million
≈ $5.28 Million
AU$149.55 Million
≈ $105.82 Million
+1.97pp
2021-06-30 3.02% AU$4.28 Million
≈ $3.03 Million
AU$141.75 Million
≈ $100.29 Million
-10.29pp
2020-06-30 13.31% AU$11.22 Million
≈ $7.94 Million
AU$84.30 Million
≈ $59.64 Million
-35.74pp
2019-06-30 49.05% AU$23.43 Million
≈ $16.58 Million
AU$47.77 Million
≈ $33.80 Million
+24.59pp
2018-06-30 24.46% AU$2.76 Million
≈ $1.95 Million
AU$11.27 Million
≈ $7.97 Million
-15.83pp
2017-06-30 40.29% AU$2.45 Million
≈ $1.73 Million
AU$6.08 Million
≈ $4.30 Million
--
pp = percentage points

About Ecofibre Ltd

AU:EOF Australia Drug Manufacturers - Specialty & Generic
Market Cap
$5.36 Million
AU$7.58 Million AUD
Market Cap Rank
#28425 Global
#1517 in Australia
Share Price
AU$0.02
Change (1 day)
+0.00%
52-Week Range
AU$0.02 - AU$0.02
All Time High
AU$3.79
About

Ecofibre Limited, together with its subsidiaries, engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia. The company operates through Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio segments. It offers cannabinoid based health products for human and pet consumption. In addition, the company provides yarn, polymer te… Read more